Purchase of One (1) Advanced Solutions Life Sciences BioAssemblyBOT 200 Cell DIVE Automation Workstation

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), The Thoracic and GI Malignancies Branch (TGMB), plans to procure, on a sole source basis, The Thoracic and GI Malignancies Branch (TGMB) requires the upgrade of a hyperplexed immunofluorescence imager, Cell DIVE (Leica Microsystems Inc.), with a BioAssemblyBOT 200 Cell DIVE automation workstation (Advanced Solutions Life Sciences, LLC). This robotic component will significantly increase experimental efficiency and accuracy in staining procedures. In addition, the bioprinting capabilities of this component will enable TGMB to create disease models for drug discovery. To be acquired from: